Revealed: The Future of the US Cell Viability Assays Market Through 2035
The US Cell Viability Assays Market is on the brink of transformation, expected to surge from USD 625.84 million in 2024 to an impressive USD 1,535.6 million by 2035. This shift represents a noteworthy CAGR of 8.5%. The evolution of assay technologies contributes significantly to this growth, enhancing the precision and effectiveness of cell viability testing. Moreover, the increasing demand...
0 Comments 0 Shares 8 Views 0 Reviews